HIV clinical trials in Missouri
8 studies for HIV are looking for participants at sites in Missouri.
Cities in Missouri
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
- KC Care Health Center, Kansas City
- Washington University School of Medicine Infectious Disease Clinical Research Unit, St Louis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07473778A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- GSK Investigational Site, Kansas City
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 28, 2026 · NCT07650916A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
- KC CARE Health Center ( Site 1506), Kansas City
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07266831Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
- Washington University School of Medicine, St Louis
Recruiting
Ages 45 to 80 · All sexes · Updated Aug 19, 2026 · NCT04949464Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
- KC CARE Health Center, Kansas City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 14, 2026 · NCT07682961A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
- GSK Investigational Site, Columbia
- GSK Investigational Site, Kansas City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT07202546Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
- Washington University St. Louis Barnes Jewish Hospital, St Louis
Recruiting
Ages 18 and older · All sexes · Updated Jun 22, 2026 · NCT06263426Menopausal HT for Women Living With HIV (HoT)
- 2101 Washington University Therapeutics (WT) CRS, St Louis
RecruitingPhase 4
Ages 40 to 60 · Women · Updated May 22, 2026 · NCT06856174From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.